Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1073/pnas.94.6.2540

http://scihub22266oqcxt.onion/10.1073/pnas.94.6.2540
suck pdf from google scholar
9122231!20124!9122231
unlimited free pdf from europmc9122231    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid9122231      Proc+Natl+Acad+Sci+U+S+A 1997 ; 94 (6): 2540-4
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • alpha-Galactosidase A deficient mice: a model of Fabry disease #MMPMID9122231
  • Ohshima T; Murray GJ; Swaim WD; Longenecker G; Quirk JM; Cardarelli CO; Sugimoto Y; Pastan I; Gottesman MM; Brady RO; Kulkarni AB
  • Proc Natl Acad Sci U S A 1997[Mar]; 94 (6): 2540-4 PMID9122231show ga
  • Fabry disease is an X-linked inherited metabolic disorder that is caused by a deficiency of alpha-galactosidase A (alpha-Gal A). Progressive deposition of neutral glycosphingolipids that have terminal a-linked galactosyl moieties in vascular endothelial cells causes renal failure along with premature myocardial infarctions and strokes in patients with this condition. No specific treatment is available for patients with this disorder at this time. An animal model of this condition would be valuable for exploring therapeutic strategies for patients with Fabry disease. We report here the generation of alpha-Gal A deficient mice by gene targeting and an analysis of the resulting phenotype. The knockout mice display a complete lack of alpha-Gal A activity. The mice, however, appeared clinically normal at 10 weeks of age. Ultrastructural analysis revealed concentric lamellar inclusions in the kidneys, and confocal microscopy using a fluorescent-labeled lectin specific for alpha-D-galactosyl residues showed accumulation of substrate in the kidneys as well as in cultured fibroblasts. Lipid analysis revealed a marked accumulation of ceramidetrihexoside in the liver and the kidneys. These findings indicate the similarity of the pathophysiological process in the mutant mice and in patients with Fabry disease. The deficiency of alpha-Gal A activity and the accumulation of material containing terminal alpha-galactosyl residues in cultured embryonic fibroblasts derived from alpha-Gal A(-/0) mice were corrected by transducing these cells with bicistronic multidrug resistance retroviruses containing human alpha-Gal A cDNA.
  • |*Fabry Disease/*enzymology/genetics/therapy[MESH]
  • |Animals[MESH]
  • |Chimera[MESH]
  • |Crosses, Genetic[MESH]
  • |Disease Models, Animal[MESH]
  • |Female[MESH]
  • |Genetic Therapy[MESH]
  • |Humans[MESH]
  • |Kidney/*enzymology/pathology/ultrastructure[MESH]
  • |Lectins[MESH]
  • |Liver/enzymology/pathology[MESH]
  • |Lysosomes/enzymology/pathology/ultrastructure[MESH]
  • |Male[MESH]
  • |Mice[MESH]
  • |Mice, Knockout[MESH]
  • |Microscopy, Electron[MESH]
  • |Plant Lectins[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box